The increasing prevalence of sleep disorders, particularly obstructive sleep apnea (OSA), is a significant driver of the market. As awareness of the health risks associated with untreated sleep apnea grows, more individuals are seeking diagnosis and treatment options.
Technological advancements in anti-snoring devices are revolutionizing the market. Smart devices equipped with sensors and mobile app connectivity allow users to track their sleep patterns and adjust treatments accordingly. These innovations are making anti-snoring solutions more effective and user-friendly.
The rise of home sleep testing is making diagnosis more accessible and convenient for patients. This trend is reducing barriers to entry for potential anti-snoring treatment users and expanding the market reach.
Personalized medicine approaches are gaining traction in the market. Customized solutions, such as 3D-printed mandibular advancement devices, are being developed to provide more effective and comfortable treatments tailored to individual patient needs.
Non-invasive treatments are becoming increasingly popular among patients seeking alternatives to traditional surgical interventions. This trend is driving the development and adoption of mandibular advancement devices, nasal dilators, and positional therapy devices.
The growing focus on the relationship between snoring, sleep quality, and overall health is expanding the market beyond traditional medical channels. Wellness and lifestyle-oriented anti-snoring solutions are emerging, appealing to a broader consumer base concerned with improving their sleep and general well-being.
Hence, telemedicine and remote patient monitoring are facilitating better follow-up care and treatment adherence. These technologies are enabling healthcare providers to adjust treatments more efficiently and improve long-term outcomes for patients using anti-snoring devices, thus leading to market growth.
Authors:
Mariam Faizullabhoy , Gauri Wani
Frequently Asked Questions (FAQ) :
The global anti-snoring treatment industry was valued at USD 1.5 billion in 2024 and is projected to grow at a CAGR of 8.5% from 2025 to 2034, driven by the increasing prevalence of sleep disorders.
The CPAP devices segment generated USD 426.3 million in 2024 and is expected to grow significantly during the forecast period as they are the standard treatment for obstructive sleep apnea (OSA) and snoring.
The U.S. anti-snoring treatment industry recorded USD 559 million in 2024 and is anticipated to witness substantial growth, driven by rising awareness about sleep disorders and their health impacts.
Key players in the market include AccuMED, Airing, Airway Management, Apnea Sciences, Fisher & Paykel Healthcare, GlaxoSmithKline, Illusion Aligners, Koninklijke Philips, Meditas, ResMed, Sleeping Well, and SomnoMed.